HIPRA launches the new single-dose presentation of ERAVAC® vaccine for companion rabbits

Filtered by {{cFt}} Quay trở về mục bản tin
Trang chủ Giới thiệu chung về HIPRA Bản tin HIPRA launches the new single-dose presentation of ERAVAC® vaccine for companion rabbits

HIPRA launches the new single-dose presentation of ERAVAC® vaccine for companion rabbits


HIPRA is launching the new single dose presentation of ERAVAC®, the first monovalent vaccine to be registered in Europe for the prevention of rabbit haemorrhagic disease type 2 (RHD-2).

This single-dose presentation has been authorized by the European Medicines Agency (EMA) with companion rabbits included in the indications as a target species.

ERAVAC® is an injectable emulsion ready for administration without the need for reconstitution beforehand. Containing 10 vials with individual doses, the new presentation is becoming the choice for active immunization of companion rabbits from 30 days of age.

With these variations, HIPRA reaffirms its commitment to the prevention of RHD-2 and demonstrates its support for the companion animals sector.

HIPRA will be present at the London Vet Show conference which is being held in London (England) on 15 and 16 November 2018

Chia sẻ

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}